Connect with us:   Email This Page  | Print
Learn more about Neuronetics, developer of the NeuroStar TMS Therapy System.
NeuroStar TMS Therapy<sup>®</sup> System

Neuronetics has developed the NeuroStar TMS Therapy® system, the first and only non-systemic and non-invasive TMS device cleared by the FDA for patients with major depression who have not benefited from prior antidepressant medication.* NeuroStar has a reliable safety record, with over 10,000 active treatments performed across all NeuroStar clinical trials demonstrating its safety.1 NeuroStar TMS therapy significantly improved patient scores on the Montgomery Asberg Depression Rating Scale (MADRS) and Hamilton Depression Rating Scale (HAMD-24) after 4-6 weeks of treatment.2 View the research.

Through 23 premier research institutions internationally, Neuronetics completed the largest clinical trial ever conducted evaluating the efficacy and safety of TMS Therapy in the treatment of major depression.

Clinical Trials Sites


Three Premier International Depression Research Centers:
  • Centre for Addiction and Mental Health, Toronto, Canada
  • Black Dog Institute, Sydney, Australia
  • Alfred Psychiatry Research Centre, Melbourne, Australia

Please note: The NeuroStar TMS Therapy trials have been completed and are no longer enrolling patients. If you think your patients with depression may benefit from treatment with NeuroStar, refer them here.

References:

  1. Janicak P, et al. Transcranial Magnetic Stimulation (TMS) in the Treatment of Major Depression: A Comprehensive Summary of Safety Experience from Acute Exposure, Extended Exposure and During Reintroduction Treatment. Journal of Clinical Psychiatry, 2008; Vol 69:222-232.
  2. Demitrack MA, Thase ME. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data. Psychopharm Bull. 2009, 42(2): 5-38.
Refer a Patient for Treatment
NeuroStar TMS Therapy may be right for your patients suffering from major depression. Refer them here.
Find a Provider

Become a NeuroStar TMS Therapy Provider
Provide your patients the new way back from depression with NeuroStar TMS Therapy®. Contact us to find out how you can bring NeuroStar into your workplace.
Contact Us


* NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. Click here for full prescribing and safety information

Copyright © 2010 Neuronetics. All Rights Reserved Sitemap  | Privacy Policy  | Terms and Conditions  | Glossary
 

You are leaving www.NeuroStarTMS.com, a website of Neuronetics. Links to all outside websites are provided as a resource to our visitors. Neuronetics accepts no responsibility for the content of other websites.

Click here to continue.